Taiwan approves first COVID-19 vaccine for human trials

For the first time ever, Taiwan's Food and Drug Administration (FDA) has given conditional approval for the experimental...

August 21, 2020 | Friday | News
AI accelerates drug repurposing to find potential COVID-19 therapies, says GlobalData

Out of all the different approaches available to find new therapies to treat COVID-19, drug repurposing is one of the fa...

August 19, 2020 | Wednesday | Analysis
Achiko extends COVID-19 ecosystem platform in Indonesia

Headquartered in Switzerland, Achiko AG (ACHI) has recently announced the deployment of Teman Sehat to a further, extend...

August 20, 2020 | Thursday | News
South Korean church donates plasma worth $83B for COVID-19 cure

At a time when the entire world is reeling under the impact of COVID-19, members of Shincheonji Church from South Korea ...

August 20, 2020 | Thursday | News
Japan studies inhibitory effect of hydroxy radicals on coronavirus

Panasonic Corporation has announced that it, in partnership with Mayo Yasugi, Associate Professor, Department of Ve...

August 20, 2020 | Thursday | News
South East Asia benefits from soaring gloves business

With the Chinese products not being utilized by some of the countries, the focus has now been shifted to the other South...

August 19, 2020 | Wednesday | News
Australia to supply Oxford COVID-19 vaccine for free

Australia has inked an agreement with British pharmaceutical giant AstraZeneca to supply Australians with the ...

August 19, 2020 | Wednesday | News
Novavax, SK Bioscience announce COVID-19 vaccine collaboration

US based Novavax, Inc., a late stage biotechnology company developing next-generation vaccines for serious infectious di...

August 17, 2020 | Monday | News
Yale School receives FDA nod for COVID-19 saliva test

The U.S. Food and Drug Administration has issued an emergency use authorization (EUA) to Yale School of Public Health fo...

August 17, 2020 | Monday | News
Australia approves COVID-19 test by Co-Diagnostics

US based Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of d...

August 17, 2020 | Monday | News
Japan picks Daiichi Sankyo for COVID-19 vaccine supply

Daiichi Sankyo Company has announced that it was selected by the Ministry of Health, Labour and Welfare of Japan to be a...

August 17, 2020 | Monday | News
Hong Kong discovers liver injury in COVID-19 patients

Researchers from the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) have recently conducted a ...

August 12, 2020 | Wednesday | News
Pfizer inks agreement with Gilead to manufacture remdesivir

Pfizer Inc. has announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead’...

August 11, 2020 | Tuesday | News
Novavax, Takeda to develop COVID-19 vaccine candidate in Japan

Novavax Inc. (NVAX), a late-stage biotechnology company headquartered in the US developing next-generation vaccines for ...

August 7, 2020 | Friday | News
"Empowering APAC healthcare delivery framework through smart innovations"

COVID-19 has exposed the inadequacies in the healthcare industry which is now evolving through vigorous transformation. ...

August 7, 2020 | Friday | Opinion
Australia provides mental health support to tackle COVID-19

The Australian Government is providing 10 additional Medicare-subsidised psychological therapy sessions for Australians ...

August 10, 2020 | Monday | News
"Transitioning to future with stronger APAC healthcare ecosystem"

The ongoing COVID-19 pandemic plaguing countries worldwide has created unprecedented change for the global economy, espe...

August 7, 2020 | Friday | Opinion
Regulations and geopolitics themes for Japanese companies to reduce dependence on China

Regulations, China Impact and Geopolitics were the top themes in 2020 for Japanese companies to reduce dependency on Chi...

August 7, 2020 | Friday | Analysis

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls